David Fallace
InvestorManaging Partner at Cure Ventures · Board director at RYNE Biotechnology Inc. · Board director at Tasca Therapeutics
Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to David
131 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.
David SchenkeinunlockedDavid: together at Denali Therapeutics (2015–2016)
David: together at Juno Therapeutics
×3David: together at Denali Therapeutics
David: together at Codiakbio
About
Managing Partner and Co-Founder of Cure Ventures with over 20 years investing in venture and alternative asset funds. Previously advised Polaris Partners and held roles at TIFF Investment Management, the Alaska Permanent Fund and GF Private Equity Group.
Contact· self-published, not guessed
Board director at RYNE Biotechnology Inc.
Intro paths
→
In turn, David can intro founders to RYNE Biotechnology Inc.'s investors below.
RYNE Biotechnology Inc.'s investors · 2
Board director at Tasca Therapeutics
Intro paths
→
In turn, David can intro founders to Tasca Therapeutics's investors below.
Tasca Therapeutics's investors · 3
Co-founders at Tasca Therapeutics
XW
Xu WuDirector
Experience
- Cure VenturesManaging Partner and Co-foundercurrent2021 — presentBoston, Massachusetts, United States
- Polaris PartnersAdviser2018 — 2019Boston, Massachusetts
- The Investment Fund for FoundationsManaging Director2016 — 2017Greater Boston
- Codiak BiosciencesInvestor2015 — 2016Greater Boston
- Denali TherapeuticsBoard Observer2015 — 2016San Francisco Bay Area
- Alaska Permanent Fund CorporationDirector - Special Opportunities2013 — 2016Juneau, Alaska
- Juno TherapeuticsBoard Observer2013 — 2014Greater Seattle Area
- Haugen Financial SystemsVice President2009 — 2013
- GF Private Equity GroupVice President2000 — 2009
Skills & more
Private Equity50Portfolio Management35Hedge Funds25Real Estate10Alternative Investments27Venture Capital43Asset Management16Asset Allocation1Corporate Development1Derivatives1Asset Managment3Emerging Markets1
From David's professional profile.
Deals · 1
RYNE Biotechnology Inc.Board seat
via Cure Ventures · filed Mar 2024 · $81.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Kenai Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Network4
Bill Amsbaugh
CTO and Partner at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Kenzie MacIsaac
Partner at Cure Ventures
May Han
Partner at Cure Ventures
Investors connected to David in public investor directories — a warm-intro map.
Frequently asked questions
- Who is David Fallace?
- Managing Partner and Co-Founder of Cure Ventures with over 20 years investing in venture and alternative asset funds. Previously advised Polaris Partners and held roles at TIFF Investment Management, the Alaska Permanent Fund and GF Private Equity Group.
- Where does David Fallace work?
- David Fallace is Managing Partner at Cure Ventures and Board director at RYNE Biotechnology Inc. and Board director at Tasca Therapeutics.
- What check size does David Fallace write?
- David Fallace typically writes checks of $100K – $5M.
- What boards does David Fallace sit on?
- David Fallace holds tracked board seats at RYNE Biotechnology Inc., Tasca Therapeutics.
- What companies has David Fallace invested in?
- Investments tracked here include Kenai Therapeutics.
- Where did David Fallace go to school?
- David Fallace studied at University at Buffalo School of Management, The State University of New York (MBA, Finance); University at Buffalo School of Law (Juris Doctor, Tax and Financial Transactions).
Same school
Also attended University at Buffalo School of Management, The State University of New York25
Sam AckermanAssistant Controller at Declaration PartnersVictoria SamlandController at Declaration PartnersJoshua GilbertInvestor at TMV LogisticsJerett SmithVice President at Ballast Point VenturesFouad AzzamPartner at EQT Life SciencesDaniel PenberthyPresident and Chief Executive Officer at Rand Capital
+ 19 more
Also attended University at Buffalo School of Law7
Douglas SylvesterGeneral Partner at Xcellerant VenturesHeather MatrangaManaging Director, Impact Investments at Village CapitalHarven DeShieldExecutive Officer, Director at Vivacelle BioDarin BifaniExecutive Officer at W4 GamesAdrian DaytonPresident at Clear View SocialBRIAN MARTINExecutive Officer at Juniper Networks
+ 1 more
Shared employers
Also worked at Polaris Partners44
Graham BrownManaging Partner at Lerer HippeauSimeon SimeonovAdvisor at One Way VenturesJonathan AngEntrepreneur Partner at Polaris PartnersDave BarrettSenior Advisory Partner at Polaris PartnersAlexandra CantleyManaging Partner at Polaris PartnersBrian CheeManaging Partner at Polaris Partners
+ 38 more
Also worked at The Investment Fund for Foundations4
Also worked at Codiak Biosciences6
Noubar AfeyanInvestor at Flagship PioneeringDoug WilliamsBiotech Executive & Founding Pillar at Pillar VCPhillip SamayoaPrincipal at Atlas VentureAvak KahvejianGeneral Partner at Flagship PioneeringAndrea DiFabioChief Legal Officer and Corporate Secretary at Xenon PharmaKathryn GoldenFounder at Sunflower TX
Also worked at Alaska Permanent Fund Corporation9
Deven MitchellExecutive Director & CEO at Alaska Permanent Fund CorporationMarcus FramptonChief Investment Officer at Alaska Permanent Fund CorporationValerie MertzChief Financial Officer at Alaska Permanent Fund CorporationSebastian VadakumcherryChief Risk & Compliance Officer at Alaska Permanent Fund CorporationFawad RazzaqueDirector of Investments — Public Equities at Alaska Permanent Fund CorporationRoss AlexanderSenior Portfolio Manager — Private Income at Alaska Permanent Fund Corporation
+ 3 more